Previous Article | Next Article ![]()
Infection and Immunity, July 2001, p. 4313-4319, Vol. 69, No. 7
Liverpool School of Tropical Medicine,
Liverpool L3 5QA,1 and Institute for
Animal Health, Compton, Newbury RG20 7NN,2
United Kingdom
Received 12 December 2000/Returned for modification 6 February
2001/Accepted 12 April 2001
Onchocerciasis is a debilitating parasitic infection caused by the
filarial nematode Onchocerca volvulus. Infections are
chronic, and persistence of the parasites for several years argues for highly adapted mechanisms of immune evasion. Due to the restricted host
repertoire of O. volvulus, we have used the cattle
parasite Onchocerca ochengi to investigate the nature of
immunomodulation underpinning these long-term infections. Cattle were
infected with a single inoculation of 350 infective-stage larvae under laboratory conditions (n = 6). Intradermal nodules
containing immature adult worms were detected from 110 days
postinfection, and microfilariae in skin were detected from day 280 postinfection. Parasite-specific responses during early infection were
nonpolarized with respect to the major Th cytokines (interleukin-4
[IL-4], IL-2, and gamma interferon [IFN- Onchocerciasis is a debilitating
parasitic infection of sub-Saharan Africa and Latin America caused by
the filarial nematode Onchocerca volvulus (2).
Characteristically, infections are chronic, and the disease this
provokes over the years is associated with a range of dermal and ocular
lesions (24). The longevity of O. volvulus
adult worms in humans is estimated to be more than a decade
(2). This persistence argues for highly adapted mechanisms of immune evasion. An understanding of the processes underlying parasite survival may open the way to new opportunities for curative treatment or the amelioration of disease.
A variety of clinical and experimental observations provide support for
the view that O. volvulus modulates the host response to
protect the parasite from immune-mediated damage. Based on the study of
infected individuals with so-called "generalized disease"
(characterized by detectable adult worms and microfilariae, with or
without pathology), these observations include depressed cellular
responses in skin tests with parasite-specific or ubiquitous recall
antigens, hypoplastic and fibrotic draining lymph nodes associated with
sites of infection, weak peripheral blood mononuclear cell (PBMC)
proliferative responses to parasite antigens in vitro, and reduced
levels of type 1 PBMC-derived cytokines (8, 11, 12, 17).
This contrasts with the relatively reactive state of patients with
"localized" onchocerciasis (or "Sowda"), in which few or no
living parasites can be detected, although onchocercal pathology is
present. In these cases, delayed hypersensitivity reactions are strong
and draining lymph nodes are swollen with active germinal centers
(6). Individuals living within areas of endemicity but
remaining free of infection (termed "putative immunes") also
exhibit heightened cellular responses. This is manifested by elevated
blastogenic responses of PBMC to parasite antigens, accompanied by
increased interleukin-2 (IL-2), IL-5, and gamma interferon (IFN- Many questions in onchocerciasis concerning the interplay between
infection status and the balance between immune responsiveness and
immune modulation remain to be addressed. To approach this, we have
turned to the natural host-parasite relationship of Onchocerca ochengi in cattle. This has many benefits. First, it obviates the
need to use chimpanzees, which, while susceptible to O. volvulus, are not natural hosts and come with ethical and logistic
constraints on their use. Second, O. ochengi is the parasite
most closely related to O. volvulus, based on phylogenetic
classification (37), and is biologically very similar. For
example, it shares the same vector (Simulium
damnosum) and is transmitted sympatrically with O. volvulus across Equatorial Africa (34). Furthermore,
O. ochengi is a natural parasite of cattle and, as such, is
highly representative of the genus Onchocerca, because this
occurs primarily in ungulate hosts. For these reasons, O. ochengi infections in cattle may be one of the best analogs of
human infection for experimental investigations.
Here we report our initial results from the O. ochengi-infected cattle system, based on experimental infections
undertaken under controlled laboratory conditions. Through the use of
single, pulse infections, we find that the response to early infection is nonpolarized with respect to T helper cytokines, follows a profile
that accords closely with parasite development, and results in the
depression of lymphoproliferation coincident with the maturation of
adult worms. Surprisingly, both IL-4 and IFN- Cattle and parasites.
Seven Jersey bull calves (Bos
taurus) were obtained locally and maintained off pasture in
flyproof accommodations. The animals were treated with a proprietary
anthelmintic (Panacur; Hoechst Roussel Vet) prior to entry into the
experiment. O. ochengi microfilariae were obtained from the
ventral skin of freshly slaughtered cattle from the Adamawa province of
northern Cameroon (35). The parasites were extracted from
skin and cryopreserved by established procedures (3, 13)
and then transported to the United Kingdom in liquid nitrogen.
Infective-stage larvae were produced by intrathoracic injection of
microfilariae into laboratory-reared blackflies (Simulium ornatum
sl.) as described previously (21). A
phosphate-buffered saline (PBS) soluble extract of adult parasites was
prepared as described previously (16).
Infection of cattle and parasitological examinations.
Three
hundred-fifty infective larvae were administered to each of six cattle
by subcutaneous injection along the ventral midline in the region of
the umbilicus. One animal was retained as an uninfected control. The
cattle were bled weekly to 6 weeks postinfection and monthly
thereafter. Physical examinations were conducted from 6 months
postinfection to detect the first appearance of palpable, intradermal
nodules containing O. ochengi adult worms (35). Examinations were repeated at monthly intervals. Nodules were excised
and dissected at the end of the experiment to confirm the identity and
viability of the parasites they contained. At each examination, three
skin biopsies were taken along the ventral midline between the
umbilicus and scrotum to detect the presence of microfilariae. The skin
was incubated for 24 h at room temperature in RPMI 1640 medium
supplemented with 20% fetal calf serum (FCS), 200 U of penicillin per
ml, and 200 µg of streptomycin per ml (all from Gibco, Paisley,
United Kingdom). Parasites in the medium were counted under low-power
microscopy. For greater sensitivity of detection of microfilariae, PCR
was employed to amplify the O-150 DNA repeat sequence of
Onchocerca (22) from skin biopsies designated
negative by parasitological methods. Skin snips were chopped finely in
buffer (100 mM NaCl, 10 mM Tris-HCl [pH 8.0], 25 mM EDTA [pH 8.0],
0.5% sodium dodecyl sulfate) containing 100 mg of proteinase K per ml
(Boehringer Mannheim GmbH, Mannheim, Germany) and incubated for 12 h at 55°C. Samples were boiled for 30 min in the presence of 20 mM
dithiothreitol (Sigma, Poole, United Kingdom) and were subjected to
three cycles of freeze-thawing. Genomic DNA was extracted with
phenol-chloroform, precipitated in 100% ethanol, and dissolved in 50 µl of water. The PCR was carried out with 1 µl of test sample per
reaction, following established procedures (22). Negative
(DNA extracted from skin of an uninfected animal) and positive (DNA
from plasmid pOVS134 containing the O-150 repeat) control templates
were analyzed in parallel.
Lymphocyte proliferation assay.
Heparinized blood was
diluted 1:1 in RPMI 1640 medium with 100 U of penicillin per ml, 100 µg of streptomycin per ml, and 10 U of heparin per ml (Sigma). PBMC
were separated by density centrifugation on Histopaque, according to
the manufacturer's instructions (Sigma). Cells were washed three times
in RPMI 1640 supplemented with 10% FCS, heparin, and antibiotics. The
cells were counted and adjusted to a density of 5 × 106 cells/ml in supplemented medium lacking
heparin. One-hundred-microliter aliquots of cell suspension were added
in triplicate to the wells of 96-well round-bottom microtiter plates
(Nunc-Gibco). Cells were stimulated with 100 µl of concanavalin A
(final concentration, 10 µg/ml; Sigma), PBS-soluble adult worm
antigen (final concentration, 10 or 50 µg/ml), or RPMI 1640 medium
alone. Plates were incubated for 72 h at 37°C in 5%
CO2 in air, and the cells were pulsed with 0.5 µCi of [3H]thymidine/well (Amersham Life
Sciences, Little Chalfont, United Kingdom). After 24 h, the cells
were harvested onto filter mats (Skatron Instruments, Ltd., Newmarket,
United Kingdom). [3H]thymidine incorporation
was measured by liquid scintillation counting and recorded as cpm.
Quantification of bovine cytokines.
Aliquots of 5 × 106 PBMC in 1 ml of supplemented RPMI 1640 medium
(10% FCS, 100 U of penicillin per ml, 100 µg of streptomycin per ml)
were added in triplicate to the wells of 24-well tissue culture plates
(Nunc). Cells were stimulated with PBS-soluble adult parasite antigen
at a final concentration of 50 µg/ml. Control cultures received an
equivalent volume of PBS alone. Plates were incubated for 72 h at
37°C in 5% CO2 in air. Culture supernatants were obtained by centrifugation of cell suspensions at 400 × g for 5 min at room temperature. Samples were stored
at Bioassays.
PBMC from a conventionally reared, uninfected
Bos taurus heifer were used as a source of B lymphocytes.
Cells were adjusted to 3 × 108 cells/ml in
PBS containing 0.5% bovine serum albumin and stained with monoclonal
antibody IL-A58 (specific for bovine Ig light chain and kindly provided
by the International Livestock Research Institute, Nairobi, Kenya).
They were incubated with anti-mouse Ig-conjugated superparamagnetic
particles (Miltenyi Biotech GmbH, Bergisch Gladbach, Germany). Labeled
cells were isolated on a MiniMacs column (Miltenyi Biotech) according
to the manufacturer's instructions. The purity of the population was
assessed by FACscan (Becton Dickinson, Oxford, United Kingdom) and
shown to contain greater than 90% B cells. The viability of cell
preparations and cultures was assessed by trypan blue exclusion.
IL-2 and IL-4 bioassays.
Culture supernatants were tested
for T- and B-cell growth activity on the 4325 long-term IL-2-maintained
cell line and purified B cells. For the IL-2 bioassay, 4325 cells were
stimulated for 3 days with recombinant bovine IL-2 (rbIL-2) produced in
a baculovirus-insect cell system (5). Cells were washed
and then made up to 5 × 105 cells/ml in
supplemented RPMI 1640 medium, and 100-µl aliquots of cell suspension
were added to an equal volume of test sample or rbIL-2, prepared as
fivefold serial dilutions. For the IL-4 assay, purified B cells were
adjusted to 106 cells/ml, and 100-µl aliquots
were dispensed into wells containing test samples diluted as described
above. Cultures were incubated for 18 to 24 h before being labeled
with 37 kBq of [3H]thymidine (3H-TdR; NEN, Du
Pont, Stevenage, United Kingdom). Cells were harvested after 6 h.
Incorporated radioactivity was determined by liquid scintillation counting.
IFN- Quantification of parasite-specific antibodies.
Parasite-specific antibody levels were measured against PBS-soluble
adult worm antigen by ELISA as described previously (18), with the following modifications. Plates were coated with antigen at 10 µg/ml, and sera were tested at a dilution of 1:400, as determined by
checkerboard titration. Murine monoclonal antibodies against bovine
IgG1, IgG2, and IgM were used at a dilution of 1:2,000. The substrate
used was 0.3 mg of 2,2'-azino-di-{3-ethylbenzthiazoline sulfonate} peroxidase (ABTS; Sigma) per ml in 1.25 mM citric
acid (pH 4.0) (BDH, Poole, United Kingdom) with 0.1% hydrogen peroxide (Merck, Poole, United Kingdom). Plates were read at 405 nm on a
Dynatech Microtiter Plate Reader (Dynatech, Billingshurst, United Kingdom).
Statistical analysis.
Data on antigen-specific cytokine
production and antibody levels were compared during the prepatent and
patent phases of infection. Mean values for each animal over the two
observation periods were log transformed, to account for nonnormal
distribution, and compared by paired t test analysis.
Parasite development following experimental infection.
Five of
six animals developed detectable O. ochengi infections, as
determined by palpable intradermal nodules or the detection of
microfilariae in the skin (Table 1). The
mean time to first detection of nodules was 267 days postinfection
(range, 110 to 600 days), with a mean number of three nodules per
animal (range, 1 to 7). The mean time to onset of microfilaridermia was
372 days postinfection (range, 279 to 532 days) with a mean peak in
microfilarial densities of 4 microfilariae/mg of skin (range, 0.1 to
8.0 microfilariae/mg). Microfilaridermia was detected in four animals
(707, 708, 709, and 712) by both microscopy and O-150 PCR.
Microfilariae could only be detected by O-150 PCR in animal 706. Microfilaridermia was maintained in animals after the onset of patency
to the end of the experiment. Animal 704 remained negative for
microfilariae as determined by microscopy and O-150 PCR throughout the
period of observation.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.7.4313-4319.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Down-Regulated Lymphoproliferation Coincides with
Parasite Maturation and with the Collapse of Both Gamma Interferon and
Interleukin-4 Responses in a Bovine Model of Onchocerciasis

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
]) produced by
antigen-stimulated peripheral blood mononuclear cells (PBMC) or serum
antibody isotypes. Antigen-induced proliferation of PBMC peaked shortly
after exposure and remained high during the prepatent infection. As the
parasites matured and animals developed patent infections, there was a
profound down-regulation of lymphoproliferation, accompanied by sharp
falls in the expression of both IL-4 and IFN-
and a gradual decline in IL-2. Levels of immunoglobulin G2 (IgG2) fell, while those of IgG1
remained high. We conclude that neither a classical Th2 response nor a
simple Th1-to-Th2 switch is sufficient to explain the immunomodulation
associated with patent Onchocerca infections. Instead,
there is an initial Th0 response, which matures into a response with
some, but not all of the features of a Th2 response. The natural
host-parasite relationship of O. ochengi in cattle may
be useful as both a descriptive and predictive tool to test more
refined models of immunomodulation in onchocerciasis.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
)
production (8, 27, 36). Experimental infections of
chimpanzees with O. volvulus have shown that
parasite-specific in vitro proliferative responses and IL-2 production
were only observed prior to the onset of patency (28).
Cellular proliferative responses of patent animals could be restored by
the addition of recombinant IL-4 or IL-6 (19). High levels
of IL-10, associated with patent infections in humans, may also be
responsible for modulation of type 1 cytokine production and
lymphoproliferation in the generalized form of the disease (8,
27).
are down-regulated in
cattle with mature O. ochengi infections, at a time when the immunoglobulin G (IgG) response is reaching a peak. These data indicate
that the system may be useful as both a descriptive and predictive tool
in onchocerciasis.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
70°C until read.
ELISA.
Bovine IFN-
in culture supernatants of
PBMC was measured by enzyme-linked immunosorbent assay (ELISA) with a
commercial kit (IDEXX Laboratories, Slough, United Kingdom) according
to the manufacturer's instructions. Plates were read on a Spectral Max 250 ELISA plate reader (Molecular Devices Corporation, Sunnyvale, Calif.) at A650. Recombinant bovine
IFN-
(Ciba Geigy, Basel, Switzerland) was used as a positive control
and to generate a standard curve. Concentrations of IFN-
in culture
supernatants were expressed as nanograms per milliliter.
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
TABLE 1.
Cytokine and serum antibody responses to parasite antigen
in six calves experimentally infected with O. ochengi,
together with data from an uninfected animal
Parasite-specific lymphoproliferative responses over the course of
infection.
Blastogenesis of PBMC induced by parasite antigen was
observed in all six cattle that received O. ochengi
infective-stage larvae (Fig. 1).
Antigen-specific lymphoproliferation was not observed in PBMC obtained
from the uninfected, sentinel animal on 20 successive occasions. Among
the infected calves, quantitative differences were observed in
lymphoproliferation; however, there was no indication that the level of
the response reflected variation in number of nodules, microfilarial
density, or prepatent period within the range of values observed (data
not shown). Lymphoproliferation rose steeply during the initial period
of larval development (Fig. 1). During the prepatent period, the
response peaked on day 33 and subsequently oscillated between phases of
reduced or elevated responsiveness from days 33 to 139 and 171 to 320, respectively. Proliferation fell to within background levels
(represented by the shaded area in Fig. 1 and calculated as the
mean + 2 standard errors [SE] for 20 readings taken from the
sentinel animal over the period of observation) on day 348. Responses
above the background level were again observed on days 500 and 538, although these were relatively low. PBMC responses to concanavalin A
were observed in all animals and were maintained over the course of
infection, with levels of proliferation always exceeding those of
parasite antigen-stimulated cultures (data not shown).
|
Parasite-specific cytokine dynamics over the course of infection. Cytokine production following stimulation of PBMC with parasite antigen was observed during recall responses in each of the six infected cattle examined (Table 1). Quantitative and temporal differences were observed in the peaks of cytokine production among individual animals, but the overall kinetics of the responses were relatively constant. For each of the cytokines, a depression in antigen-induced production occurred at the end of the prepatent period (Table 1). No differences in the levels of cytokines that reflected variation in the number of nodules, prepatent period, or density of microfilariae in the skin were seen (data not shown). Background responses measured in the sentinel animal were consistently low (Table 1).
Responses for IFN-
, IL-4, and IL-2 measured longitudinally over a
period of 538 days are shown in Fig. 2.
Control values for the sentinel animal are represented by shading and
were calculated as the mean + 2 SE for 18 readings taken over the
period of observation. IFN-
production rose sharply after infection
and peaked for the first time on day 27 (Fig. 2A). Levels of IFN-
remained elevated and relatively constant through 210 days after
infection. A major peak of production was observed in all animals on
day 240, which was followed by a rapid decline. IFN-
levels from
infected cattle were significantly depressed following the onset of
patent infections (Table 1, P < 0.05) and had fallen
to within control levels by day 290 (Fig. 2A). With the exception of a
weak and transient response detected on day 320, no further IFN-
production above background values was observed.
|
Parasite-specific antibody dynamics over the course of
infection.
Parasite-specific antibody responses occurred in all
six infected cattle and are illustrated in Fig.
3. As with the cellular responses,
variations in the responses among individual animals were seen (Table
1), but there was no indication that this reflected variation in number
of nodules or prepatent period. Antibody levels did, however, increase
as a function of infection intensity as measured by microfilarial
densities in skin (data not shown).
|
| |
DISCUSSION |
|---|
|
|
|---|
Cattle infected with O. ochengi under experimental conditions developed intradermal nodules, patent infections, and chronic microfilaridermia in a chronology equivalent to that predicted from natural infections (1, 33). By using a single dose of infective larvae to initiate infection, we were able to interpret the dynamics of the immune response in relation to biological events in the life history of the parasite.
The profile of lymphoproliferation and cytokine production over the course of infection showed significant changes that correlated closely with key stages in parasite development. For example, the sharp rise in proliferation shortly after infection corresponds with the period of development from third-stage larva to the fourth larval moult (2). The subsequent phases of reduced and elevated responsiveness coincide with the periods of adult worm development prior to and after the establishment of intradermal nodules. The final drop in the proliferative response to background levels accords with the end of the prepatent period. Interestingly, this down-regulation occurred in all six infected animals, irrespective of the number of nodules or of our ability to detect microfilariae in the skin. This suggests that very few parasites are needed to achieve immune modulation. That all of the animals were infected and immunologically competent was demonstrated by their antibody responses, which rose even while the markers of cellular responsiveness were being depressed. We assume that the failure to find nodules or microfilariae in one of the six animals is likely to be attributable to technical limitations in detecting small tissue-dwelling nematodes in cattle.
Trends in the expression of cytokines by antigen-stimulated PBMC also varied over time in a similar fashion to lymphoproliferative responses. Levels of IL-4 rose particularly steeply during the development of third- to fourth-stage larvae and remained high, but not beyond the prepatent period. The balance of cytokines observed during the prepatent infection argues for a nonpolarized T helper response during first contact with parasite transmission.
The total IgG parasite-specific antibody response showed a rapid rise
in titer following the infection with infective-stage larvae. The
levels peaked coincident with the first detection of nodules and
presumably following the final larval moult. The response then peaked
at the onset of patency, when microfilariae were first appearing in the
skin, and remained elevated thereafter. Bovine IgG consists of two
isotypes, IgG1 and IgG2 (with allotypes 2a and 2b), neither of which is
a homologue of human or murine IgG isotypes. However, regulation of
isotype switching in cattle, like that in humans and mice, is
reciprocally regulated by IL-4 and IFN-
, with IL-4 upregulating IgG1
expression and IFN-
upregulating IgG2 (9). The response
was dominated by the IgG1 isotype, which showed an accentuated peak at
the onset of patency. This result clearly demonstrates that the
animals, despite having impaired cellular responses, and particularly
an inability to induce parasite-specific IL-4, were capable of inducing
an antibody response. This suggests that the antibody response being
generated at the onset of patency may be regulated by an alternative
cytokine that is unaffected by the immunomodulatory changes affecting
IL-4. IFN-
has been shown to stimulate IgG2 production from bovine B
cells in vitro (9). In infected animals, parasite-specific
IgG2 levels decreased to preinfection levels following the ablation of
IFN-
production, which may suggest IFN-
regulated IgG2 responses
in vivo.
The depressed proliferative and elevated antibody responses of
chronically infected cattle described here reflect what has been
reported for onchocerciasis patients and experimentally infected chimpanzees (12, 19, 28, 36). The down-regulation of
parasite-specific IL-2, IL-4, and IFN-
production observed in this
study is particularly informative. If such a down-regulation of
cytokine production occurred with O. volvulus infections, it
would explain the inability of several studies of onchocerciasis
patients to detect parasite-specific IL-2, IL-4, and IFN-
production
(8, 10, 29, 30). A role for IL-4 production in
parasite-specific proliferative responses is supported by the
observation that the addition of recombinant IL-4 to antigen-stimulated
PBMC cultures of O. volvulus-infected chimpanzees partially
restored proliferative responses (19). Recent studies of
children with onchocerciasis have also shown that IL-4 responses are
down-regulated in relation to increasing microfilarial density. This
down-regulation also extends to responses induced by
Mycobacterium tuberculosis PPD, emphasizing that
immunomodulation caused by Onchocerca infection may
influence responses to concurrent infections (31).
Several mechanisms have been put forward to explain the underlying
mechanisms of T-cell down-regulation in filariasis (20). In studies of lymphatic filariasis, IL-10 has been shown to regulate T-cell responses in both animal models and clinical studies (23, 25). In onchocerciasis, IL-10 has also been shown to play a role, although additional mechanisms are thought to be involved (26). Recent studies have identified a subpopulation of
"Th3" cells, isolated from the PMBC of O. volvulus-infected individuals, which mediate cellular
hyporesponsiveness through the production of IL-10 and transforming
growth factor
(TGF-
) (7).
Most of these studies, including ours, have used crude soluble extracts of parasites that contain a complex mixture of antigens and immunoreactive molecules. A number of defined molecules have been shown to potentially contribute to the induction of T-cell hyporesponsiveness, including two secreted proteins from the rodent filaria Acanthocheilonema viteae: a cysteine protease inhibitor and a phosphorylcholine-containing glycoprotein (14, 15). Additional immunomodulatory molecules that may also influence immune regulation include lipopolysaccharide (LPS)-like molecules derived from endosymbiotic Wolbachia bacteria (32). LPS-like molecules from extracts of O. volvulus and O. ochengi have been shown to induce IL-10 from human monocytes, leading to the down-regulation of major histocompatibility complex and costimulatory molecules (4), both of which are likely to result in impaired antigen presentation.
The ability to investigate the dynamics of the induction of these mechanisms in a natural host-parasite system, as described here, provides a powerful model to define the temporal induction of T-cell activation and subsequent down-regulation. In addition, it will provide the means to address the functional consequences of immune down-regulation for the survival of parasites and/or the regulation of immunopathogenesis.
| |
ACKNOWLEDGMENTS |
|---|
We thank Mark Bronsvoort and David Ekale for assistance in the collection of parasites in Ngaoundere, Cameroon; Nigel Jones and colleagues at the Veterinary Station of the University of Liverpool for animal husbandry; and Tom Unnasch of the University of Alabama at Birmingham, for the provision of plasmid pOVS134.
This study was supported by a grant (no.05594) from the Edna McConnell Clark Foundation (United States) and was conducted with the approval of the Ministry of Agriculture, Fisheries and Food and Home Office of the United Kingdom. Mark Taylor thanks the Wellcome Trust for fellowship support (no. 047176).
| |
FOOTNOTES |
|---|
* Corresponding author. Present address: International Livestock Research Institute, P.O. Box 30709, Nairobi Kenya. Phone: 254-2 630743. Fax: 254-2 631499. E-mail: sgraham{at}cgiar.org.
We are sad to report the death of R.A.C. shortly before completion
of the manuscript.
Editor: J. M. Mansfield
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Achu-Kwi, M. D., W. H. Daiber, A. Renz, G. Wahl, and S. Wanji. 1994. Prepatency period and some aspects of the epizootiology of Onchocerca ochengi infestations in cattle in the Adamawa plateau, Cameroon. Parasite 1:10. |
| 2. |
Bianco, A. E.
1991.
Onchocerciasis river blindness, p. 138-189.
In
C. N. L. Macpherson, and P. S. Craig (ed.), Parasitic helminths, zoonoses, and human health in Africa. Unwin Hayman Press, London, United Kingdom.
|
| 3. | Bianco, A. E., P. J. Ham, K. El Sinnary, and G. S. Nelson. 1980. Large-scale recovery of Onchocerca microfilariae from naturally infected cattle and horses. Trans. R. Soc. Trop. Med. Hyg. 74:109[CrossRef]. |
| 4. | Brattig, N. W., U. Rathjens, M. Ernst, F. Geisinger, A. Renz, and F. W. Tischendorf. 2000. Lipopolysaccharide-like molecules derived from Wolbachia endobacteria of the filaria Onchocerca volvulus are candidate mediators in the sequence of inflammatory and anti-inflammatory responses of human monocytes. Microbe Infect. 10:1147-1157. |
| 5. | Collins, R. A., H. K. Tayton, K. I. Gelder, P. Britton, and G. Oldham. 1994. Cloning and expression of bovine and porcine interleukin-2 in baculovirus and analysis of species cross-reactivity. Vet. Immunol. Immunopathol. 40:313-324[CrossRef][Medline]. |
| 6. |
Connor, D. H.,
D. W. Gibson,
R. C. Neafie,
B. Merghi, and A. A. Buck.
1983.
Sowda onchocerciasis in North Yemen: a clinicopathologic study of 18 patients.
Am. J. Trop. Med. Hyg.
32:123-137.
|
| 7. |
Doetze, A.,
J. Satoguina,
G. Burchard,
T. Rau,
C. Loliger,
B. Fleischer, and A. Hoerauf.
2000.
Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shift.
Int. Immunol.
12:623-630 |
| 8. | Elson, L. H., M. H. Calvopina, W. Y. Paredes, E. N. Araujo, J. E. Bradley, R. H. Guderian, and T. B. Nutman. 1995. Immunity in onchocerciasis: putative immune persons produce a Th1-like response to Onchocerca volvulus. J. Infect. Dis. 171:652-658[Medline]. |
| 9. | Estes, D. M. 1996. Differentiation of B cells in the bovine. Role of cytokines in immunoglobulin isotype expression. Vet. Immunol. Immunopathol. 54:61-67[CrossRef][Medline]. |
| 10. | Freedman, D. O., A. Lujan-Trangay, C. Steel, C. Gonzalez-Peralta, and T. B. Nutman. 1991. Immunoregulation in onchocerciasis: functional and phenotypic abnormalities of lymphocyte subsets and changes with therapy. J. Clin. Investig. 88:231-238. |
| 11. |
Gallin, M.,
K. Edmonds,
J. J. Ellner,
K. D. Erttmann,
A. T. White,
H. S. Newland,
H. S. Taylor, and B. M. Greene.
1988.
Cell-mediated immune responses in human infection with Onchocerca volvulus.
J. Immunol.
140:1999-2007 |
| 12. | Greene, B. M., A. A. Gbakima, E. J. Albiez, and H. R. Taylor. 1985. Humoral and cellular immune responses to Onchocerca volvulus infection in man. Rev. Infect. Dis. 7:789-795[Medline]. |
| 13. | Ham, P. J., S. Townson, E. R. James, and A. E. Bianco. 1981. An improved technique for the cryopreservation of Onchocerca microfilariae. Parasitology 83:139-146[Medline]. |
| 14. | Harnett, W., M. R. Deehan, K. M. Houston, and M. M. Harnett. 1999. Immunomodulatory properties of a phosphorylcholine-containing secreted filarial glycoprotein. Parasite Immunol. 21:601-608[CrossRef][Medline]. |
| 15. | Hartmann, S., B. Kyewski, B. Sonnenburg, and R. Lucius. 1997. A filarial cysteine protease inhibitor down-regulates T cell proliferation and enhances interleukin-10 production. Eur. J. Immunol. 27:2253-2260[Medline]. |
| 16. | Hogarth, P. J., and A. E. Bianco. 1998. IL-5 dominates cytokine responses during expression of protective immunity to Onchocerca lienalis microfilariae in mice. Parasite Immunol. 21:81-88. |
| 17. | Kilian, H. D., and G. Nielsen. 1989. Cell-mediated and humoral immune responses to BCG and rubella vaccinations and to recall antigens in onchocerciasis patients. Trop. Med. Parasitol. 40:445-453[Medline]. |
| 18. | Kuo, Y. M., and A. E. Bianco. 1995. Temporal changes in the humoral immune response of cattle during experimental infections with Onchocerca lienalis. Parasite Immunol. 17:393-404[Medline]. |
| 19. | Luder, C. G. K., P. T. Soboslay, A. M. Prince, B. M. Greene, R. Lucius, and H. Schultz-Key. 1993. Experimental onchocerciasis in chimpanzees: cellular responses and antigen recognition after immunization and challenge with Onchocerca volvulus infective third-stage larvae. Parasitology 107:87-97. |
| 20. |
Maizels, R. M.,
M. J. Holland,
F. H. Falcone,
X. X. Zang, and M. Yazdanbakhsh.
1999.
Vaccination against helminth parasites the ultimate challenge for vaccinologists?
Immunol. Rev.
171:125-147[CrossRef][Medline].
|
| 21. | McCall, P. J., H. Townson, and A. J. Trees. 1992. Morphometric differentiation of the Onchocerca volvulus and Onchocerca ochengi infective larvae. Trans. R. Soc. Trop. Med. Hyg. 86:63-65[CrossRef][Medline]. |
| 22. | Meredith, S. E. O., G. Lando, A. A. Gbakima, P. A. Zimmerman, and T. R. Unnasch. 1991. Onchocerca volvulus: application of the polymerase chain reaction to identification and strain differentiation of the parasite. Exp. Parasitol. 73:335-344[CrossRef][Medline]. |
| 23. |
Osborne, J., and E. Devaney.
1999.
Interleukin-10 and antigen-presenting cells actively suppress Th1 cells in BALB/c mice infected with the filarial parasite Brugia pahangi.
Infect. Immun.
67:1599-1605 |
| 24. | Ottesen, E. A. 1995. Immune responsiveness and the pathogenesis of human onchocerciasis. J. Infect. Dis. 171:659-671[Medline]. |
| 25. | Ravichandran, M., S. Mahanty, V. Kumaraswami, T. B. Nutman, and K. Jayaraman. 1997. Elevated IL-10 mRNA expression and downregulation of Th1-type cytokines in microfilaraemic individuals with Wurchereria bancrofti infection. Parasite Immunol. 19:69-77[CrossRef][Medline]. |
| 26. |
Soboslay, P. T.,
C. G. K. Luder,
S. Riesch,
S. M. Geiger,
M. Banla,
E. Batchassi,
A. Stadler, and H. Schultz-Key.
1999.
Regulatory effects of Th1-type (IFN- , IL-12) and Th2-type cytokines (IL-10, IL-13) on parasite-specific cellular responsiveness in Onchocerca volvulus-infected humans and exposed endemic controls.
Immunology
97:219-225[CrossRef][Medline].
|
| 27. | Soboslay, P. T., S. M. Geiger, N. Weiss, M. Banla, C. G. K. Luder, C. M. Drerweck, E. Batchassi, B. A. Boatin, A. Stadler, and H. Schultz-Key. 1997. The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection. Immunology 90:592-599[CrossRef][Medline]. |
| 28. | Soboslay, P. T., C. M. Dreweck, H. R. Taylor, B. Brottman, P. Wenk, and B. M. Greene. 1991. Experimental onchocerciasis in chimpanzees. Cell-mediated immune responses, and production and effects of IL-1 and IL-2 with Onchocerca volvulus infection. J. Immunol. 147:346-353[Abstract]. |
| 29. | Steel, C., and T. B. Nutman. 1993. Regulation of IL-5 in onchocerciasis. A critical role for IL-2. J. Immunol. 153:5511-5518. |
| 30. | Steel, C., A. Lujan-Trangay, C. Gonzalez-Peralta, G. Zea-Flores, and T. B. Nutman. 1994. Transient changes in cytokine profiles following ivermectin treatment of onchocerciasis. J. Infect. Dis. 170:962-970[Medline]. |
| 31. | Stewart, G. R., M. Boussinesq, T. Coulson, L. Elson, T. Nutman, and J. E. Bradley. 1999. Onchocerciasis modulates the immune response to mycobacterial antigens. Clin. Exp. Immunol. 117:517-523[CrossRef][Medline]. |
| 32. |
Taylor, M. J.,
H. F. Cross, and K. Bilo.
2000.
Inflammatory responses induced by the filarial nematode Brugia malayi are mediated by lipopolysaccharide-like activity from endosymbiotic Wolbachia bacteria.
J. Exp. Med.
191:1429-1436 |
| 33. | Tchakouté, V. L., M. Bronsvoort, V. Tanya, A. Renz, and A. J. Trees. 1999. Chemoprophylaxis of Onchocerca infections: in a controlled, prospective study ivermectin prevents calves becoming infected with O. ochengi. Parasitology 118:195-199. |
| 34. | Trees, A. J. 1992. Onchocerca ochengi: mimic, model or modulator of O. volvulus. Parasitol. Today 8:337-339[CrossRef][Medline]. |
| 35. | Wahl, G., M. D. Achu-Kwi, D. Mbah, O. Dawa, and A. Renz. 1994. Bovine onchocerciasis in North Cameroon. Vet. Parasitol. 52:297-311[CrossRef][Medline]. |
| 36. | Ward, D. J., T. B. Nutman, G. Zea-Flores, C. Portocarrero, A. Lujan, and E. A. Ottesen. 1988. Onchocerciasis and immunity in humans: enhanced T cell responsiveness to parasite antigen in putatively immune individuals. J. Infect. Dis. 157:536-543[Medline]. |
| 37. | Xie, H., O. Bain, and S. A. Williams. 1994. Molecular phylogenetic studies on filarial parasites based on 5s ribosomal spacer sequences. Parasite 1:141-151[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»